Myriad Genetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.

About MYGN

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A.

CEO

Samraat S Raha

CEOSamraat S Raha

Employees

2,700

Employees2,700

Headquarters

Salt Lake City, Utah

HeadquartersSalt Lake City, Utah

Founded

1991

Founded1991

Employees

2,700

Employees2,700

MYGN Key Statistics

Market cap

383.00M

Market cap383.00M

Price-Earnings ratio

-3.70

Price-Earnings ratio-3.70

Dividend yield

—

Dividend yield—

Average volume

4.36M

Average volume4.36M

High today

$4.18

High today$4.18

Low today

$4.06

Low today$4.06

Open price

$4.12

Open price$4.12

Volume

2.19M

Volume2.19M

52 Week high

$29.30

52 Week high$29.30

52 Week low

$3.81

52 Week low$3.81

MYGN News

TipRanks 3d

Myriad Genetics price target lowered to $9 from $12.50 at Piper Sandler

Piper Sandler lowered the firm’s price target on Myriad Genetics (MYGN) to $9 from $12.50 following quarterly results. The firm keeps an Overweight rating on th...

Analyst ratings

47%

of 17 ratings

Buy

29.4%

Hold

47.1%

Sell

23.5%

People also own

Based on the portfolios of people who own MYGN. This list is generated using Robinhood data, and it’s not a recommendation.